Enovis ENOV Prevention & Recovery — Payments for asset acquisitions
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Enovis in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.
The source filing: Enovis’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001420800-26-000035
For the transactions in P&R completed during the year ended December 31, 2025, the Company (i) paid a total of $7.8 million, net of cash received, and recorded estimated contingent consideration for future expected payments of $1.9 million for the acquisition of two businesses, and (ii) paid a total of $6.5 million in cash and recorded a $8.3 million liability for deferred payments for an asset acquisition of intellectual property. The transactions added complementary product offerings to the P&R segment.
Item 1. Financial Statements
FAQ
- What is Enovis's prevention & recovery — payments for asset acquisitions?
- Enovis (ENOV) reported prevention & recovery — payments for asset acquisitions of $6.5M in Q1 2026.
- How has Enovis's prevention & recovery — payments for asset acquisitions changed year-over-year?
- Enovis's prevention & recovery — payments for asset acquisitions increased by 300.0% year-over-year, from $1.63M to $6.5M.
- What does prevention & recovery — payments for asset acquisitions mean?
- Cash outflows specifically allocated to the purchase of intangible assets, intellectual property, or specific medical technology assets within the Prevention & Recovery segment. This metric highlights the segment's investment in proprietary technology and clinical solutions outside of full business acquisitions.
Ask your AI about Enovis's prevention & recovery — payments for asset acquisitions.
Connect your AI assistant and compare segments, right in your chat.
